What is TetraScience?
TetraScience operates as the R&D Data Cloud company, dedicated to revolutionizing life sciences research by enhancing discovery processes and improving human health outcomes. Its platform provides life sciences organizations with the necessary flexibility, scalability, and data-centric capabilities for seamless access to harmonized and actionable scientific data. The Tetra R&D Data Cloud is actively utilized by enterprise pharma and biotech companies, featuring an extensive integration network of laboratory instruments, informatics applications, CRO/CDMOs, and analytics partners. This open platform fosters interoperability and creates an innovation feedback loop crucial for the future of R&D in the life sciences.
How much funding has TetraScience raised?
TetraScience has raised a total of $103M across 3 funding rounds:
Series A
$8M
Series B
$80M
Private Equity
$15M
Series A (2019): $8M with participation from Waters, Founder Collective, Y Combinator, Floodgate Capital, First Round Capital, and Underscore VC
Series B (2021): $80M led by Insight Partners and Alkeon Capital Management
Private Equity (2026): $15M, investors not publicly disclosed
Key Investors in TetraScience
Insight Partners
Insight Partners is a global venture capital and private equity firm specializing in high-growth technology and software companies. They provide strategic guidance and operational support to help their portfolio companies scale effectively.
Waters
Waters Corporation is a leader in analytical laboratory instrumentation, software, and services, playing a critical role in scientific research and development across various industries, including pharmaceuticals and biotechnology.
Founder Collective
Founder Collective is a venture capital firm that focuses on early-stage investments, supporting entrepreneurs from the initial idea phase through to significant growth milestones.
What's next for TetraScience?
The substantial enterprise-level funding and recent strategic investment signal a period of accelerated growth and market penetration for TetraScience. This capital will likely be directed towards expanding its integration network, enhancing its data cloud capabilities, and strengthening its position within the competitive life sciences technology landscape. The company's focus on interoperability and data accessibility positions it to capitalize on the increasing demand for efficient R&D processes, potentially leading to further strategic partnerships and broader adoption across the global pharmaceutical and biotech industries.
See full TetraScience company page
